RecruitingPhase 4NCT04860141

Efficacy of Preoperative Administration of Gabapentin in 3rd Molar Dental Extraction.

Efficacy of Preoperative Administration of Gabapentin in Managing Intraoperative and Postoperative Pain From Third Molar Extractions.


Sponsor

Loma Linda University

Enrollment

98 participants

Start Date

Jun 16, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

This study is a double-blind, randomized, prospective, placebo-controlled single-center clinical research study in which 600 mg of gabapentin or placebo will be administered 2 hours preoperatively to 49 patients each undergoing wisdom teeth extraction. We will measure intraoperative opioid use, severity of pain, the number of analgesics taken, and side effect profiles (e.g. nausea/vomiting, dizziness) at the following intervals, 4 hour, 8 hour, 12 hour, 24, and 72 hour post-procedure.


Eligibility

Min Age: 18 YearsMax Age: 59 Years

Inclusion Criteria6

  • Subjects must be at or older than 18.
  • Screened body mass index (BMI) between 18-35 kg/m2.
  • American Society of Anesthesiologists Classification I and II.
  • Subjects must be willing and able to comply with protocol requirements.
  • Subjects must be able to understand the informed consent and must be able to sign a written informed consent form prior to the initiation of any study procedures.
  • A subject must have at least 1 partial or fully impacted third molar tooth removal.

Exclusion Criteria8

  • hypersensitivity to gabapentinoids;
  • history of chronic opioid or gabapentin usage (regular use of opioids \>3 months)
  • history of recreational drug usage
  • a history or clinical manifestations of significant metabolic, hematologic, pulmonary, cardiovascular, gastrointestinal, neurologic, hepatic, renal, urologic, musculoskeletal, psychiatric, or immunologic disorder, any acute, clinically significant illness or condition within 14 days prior to Day 1.
  • Patients with baseline pain.
  • Patients with any oral pathology will be excluded.
  • Pregnant or breastfeeding patients
  • An individual not legally competent to consent (e.g., incapacitated individuals, incompetents, minors)

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGGabapentin 600mg

The patient will take gabapentin 600mg 2 hours prior to the procedure

DRUGPlacebo

the patient will take a pill that looks like gabapentin 2 hours prior to the procedure


Locations(1)

Loma Linda University Health

Loma Linda, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04860141


Related Trials